Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
Jonathan So, Nathaniel W. Mabe, Bernhard Englinger, et al.
JCI Insight (2022) Vol. 7, Iss. 19
Open Access | Times Cited: 23

Showing 23 citing articles:

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy
Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4095-4111
Open Access | Times Cited: 41
Targeting synthetic lethal paralogs in cancer
Colm J. Ryan, Ishan Mehta, Narod Kebabci, et al.
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 397-409
Open Access | Times Cited: 38
Combination Approaches to Target PD-1 Signaling in Cancer
Emily K. Moore, Marianne Strazza, Adam Mor
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
The present and future of the Cancer Dependency Map
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 4
The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase
Eva Monte-Serrano, Patricia Morejón‐García, Ignacio Campillo‐Marcos, et al.
Epigenetics & Chromatin (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin
Elena Navarro-Carrasco, Aurora Campos-Díaz, Eva Monte-Serrano, et al.
Chemico-Biological Interactions (2024) Vol. 391, pp. 110908-110908
Open Access | Times Cited: 3
Developmental origins shape the paediatric cancer genome
Xiaolong Chen, Wentao Yang, Charles W.M. Roberts, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 382-398
Closed Access | Times Cited: 3
Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε
F. Gama, Luiz Antônio Dutra, Michael Hawgood, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8609-8629
Closed Access | Times Cited: 3
Paralog-based synthetic lethality: rationales and applications
Yucui Xin, Yingsheng Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
VRK1 promotes DNA-induced type I interferon production
Zhechen Fan, Xiong Wang, Hao Cheng, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Advances in synthetic lethality modalities for glioblastoma multiforme
Seidu A. Richard
Open Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy
B. Hilda Ye, Di‐Fei Li, Xinyun Li, et al.
Cancer Letters (2024) Vol. 597, pp. 217010-217010
Closed Access | Times Cited: 1
Targeting the Sodium-Potassium Pump as a Therapeutic Strategy in Acute Myeloid Leukemia
Constanze Schneider, Hermes Spaink, Gabriela Alexe, et al.
Cancer Research (2024) Vol. 84, Iss. 20, pp. 3354-3370
Closed Access | Times Cited: 1
Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
Ananna Bhadra Arna, Hardikkumar Patel, Ravi Shankar Singh, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 3
2D and 3D multiplexed subcellular profiling of nuclear instability in human cancer
Shannon Coy, Brian Cheng, J. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Nuclear functions regulated by the VRK1 kinase
Pedro A. Lazo
Nucleus (2024) Vol. 15, Iss. 1
Open Access
Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT
Ryuhjin Ahn, Alicia D. D’Souza, Lü Long, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cell context-specific Synthetic lethality Prediction and Mechanism Analysis
Yucui Xing, Mengchen Pu, Kaiyang Cheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Closed Access | Times Cited: 1
Novel dihydropteridinone derivatives as potent and selective inhibitors of the understudied human vaccinia-related kinase 1 (VRK1)
F. Gama, Luiz Antônio Dutra, Michael Hawgood, et al.
(2023)
Open Access | Times Cited: 1
VRK3 depletion induces cell cycle arrest and metabolic reprogramming of Pontine Diffuse Midline Glioma (DMG)-K27 altered cells
Virginie Ménez, Thomas Kergrohen, Tal Shasha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The role of VRK1 in chromatin remodeling: regulation of histone post-translational modifications and epigenetic enzymes
Eva Monte Serrano
(2023)
Open Access
VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma - H3K27 altered cells
Virginie Ménez, Thomas Kergrohen, Tal Shasha, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
2D and 3D Multiplexed Subcellular Profiling of Nuclear Instability in Human Cancer
Shannon Coy, Brian Cheng, J. Lee, et al.
(2023)
Open Access
Page 1

Scroll to top